Kenya - English - Pharmacy and Poisons Board

beximco pharmaceuticals ltd. 19 dhanmondi r/a road no. 7 dhaka-1205 - ketotifen - syrup - 1mg/5ml - other antihistamines for systemic use

Kenya - English - Pharmacy and Poisons Board

beximco pharmaceuticals ltd. 19 dhanmondi r/a road no. 7 dhaka-1205 - ketotifen - tablet - 1 mg - other antihistamines for systemic use

Kenya - English - Pharmacy and Poisons Board

beximco pharmaceuticals ltd 19 dhanmandi r/a road no. 2 dhaka 1205 bangladesh - diclofenac diethylamine - gel - 10 mg per gm - non-steroidal anti-inflammatory preparations for

Kenya - English - Pharmacy and Poisons Board

beximco pharmaceuticals ltd. 19 dhanmondi r/a road no. 7 dhaka-1205 - aceclofenac - tablet - 100 mg - non-steroidal

Zimbabwe - English - Medicines Control Authority

beximco pharmaceuticals ltd - moxifloxacin hydrochloride - solution/drops; ophthalmic - 5 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

beximco pharmaceuticals australia pty ltd -

Canada - English - Health Canada

beximco pharmaceuticals canada limited - moxifloxacin (moxifloxacin hydrochloride) - solution - 0.5% - moxifloxacin (moxifloxacin hydrochloride) 0.5% - antibacterials

Bangladesh - English - DGDA (Directorate General of Drug Administration)

beximco pharmaceuticals ltd. - empagliflozin - tablet - 10 mg - each film coated tablet contains empagliflozin inn 10 mg. - jardian is indicated as an adjunct to diet and exercise for the treatment of type-2 diabetes. it can be given alone or in combination with other oral antidiabetic agents. it is also indicated for reduction in cardiovascular risk in type-2 diabetic patients.

Bangladesh - English - DGDA (Directorate General of Drug Administration)

beximco pharmaceuticals ltd. - empagliflozin - tablet - 25 mg - each film coated tablet contains empagliflozin inn 25 mg. - jardian is indicated as an adjunct to diet and exercise for the treatment of type-2 diabetes. it can be given alone or in combination with other oral antidiabetic agents. it is also indicated for reduction in cardiovascular risk in type-2 diabetic patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

beximco pharmaceuticals australia pty ltd - ascorbic acid,betacarotene,calcium hydrogen phosphate,colecalciferol,cyanocobalamin,dl-alpha-tocopheryl acetate,ferrous fumarate,folic acid,heavy magnesium oxide,nicotinamide,potassium iodide,pyridoxine hydrochloride,riboflavin,thiamine nitrate,zinc sulfate monohydrate -